Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2011 (2011), Article ID 325189, 8 pages
http://dx.doi.org/10.1155/2011/325189
Research Article

Symptom Burden, Survival and Palliative Care in Advanced Soft Tissue Sarcoma

1Palliative Care Department, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK
2Division of Medicine, Institute of Cancer Research, 123 Old Brompton Road, London SW7 3RP, UK
3National Heart and Lung Institute, Imperial College, London SW7 2AZ, UK
4Sarcoma Unit, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK

Received 29 June 2011; Revised 16 August 2011; Accepted 31 August 2011

Academic Editor: Alessandro Gronchi

Copyright © 2011 Nicholas J. Gough et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Sinha and A. H. S. Peach, “Diagnosis and management of soft tissue sarcoma,” British Medical Journal, vol. 342, no. 7789, pp. 157–162, 2011. View at Publisher · View at Google Scholar
  2. R. Grimer, I. Judson, D. Peake, and B. Seddon, “Guidelines for the management of soft tissue sarcomas,” Sarcoma, vol. 2010, Article ID 506182, 15 pages, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. M. A. Clark, C. Fisher, I. Judson, and J. Meirion Thomas, “Soft-tissue sarcomas in adults,” The New England Journal of Medicine, vol. 353, no. 7, pp. 701–711, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. J. M. Coindre, P. Terrier, L. Guillou et al., “Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers sarcoma group,” Cancer, vol. 91, no. 10, pp. 1914–1926, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. M. F. Brennan, K. Alektiar, and R. Maki, “Soft tissue sarcoma,” in Cancer: Principles and Practice of Oncology, V. DeVita Jr., S. Hellamn, and S. Rosenberg, Eds., pp. 1741–1794, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 6th edition, 2008. View at Google Scholar
  6. L. K. F. Temple and M. F. Brennan, “The role of pulmonary metastasectomy in soft tissue sarcoma,” Seminars in Thoracic and Cardiovascular Surgery, vol. 14, no. 1, pp. 35–44, 2002. View at Google Scholar · View at Scopus
  7. V. Karavasilis, B. M. Seddon, S. Ashley, O. Al-Muderis, C. Fisher, and I. Judson, “Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients,” Cancer, vol. 112, no. 7, pp. 1585–1591, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. M. Van Glabbeke, J. Verweij, I. Judson, and O. S. Nielsen, “Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas,” European Journal of Cancer, vol. 38, no. 4, pp. 543–549, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Minchom, R. L. Jones, C. Fisher et al., “Clinical benefit of second-line palliative chemotherapy in advanced soft-tissue sarcoma,” Sarcoma, vol. 2010, Article ID 264360, 8 pages, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. R. S. Benjamin, “Grade 3 nausea, vomiting, and myelosuppression or progressive, metastatic sarcoma?” Journal of Clinical Oncology, vol. 5, no. 6, pp. 833–835, 1987. View at Google Scholar · View at Scopus
  11. V. Bramwell, D. Anderson, and M. Charette, “Doxorubicin based chemotherapy for the palliative treatment of adults with locally advanced or metastatic soft tissue sarcoma,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD003293, 2001. View at Google Scholar
  12. P. Y. Kuo, J. T. C. Yen, G. M. Parker et al., “The prevalence of pain in patients attending sarcoma outpatient clinics,” Sarcoma, vol. 2011, Article ID 813483, 6 pages, 2011. View at Publisher · View at Google Scholar · View at PubMed
  13. World Health Organization 2005 definition, “Palliative care,” http://www.who.int/cancer/palliative/.
  14. “Improving outcomes for people with sarcoma,” National Institute for Health and Clinical Excellence. The Evidence review. 2006, http://www.nice.org.uk/.
  15. “Improving supportive and palliative care for adults with cancer: the Manual,” National Institute for Health and Clinical Excellence (NICE), March 2004, http://www.nice.org.uk/.
  16. J. S. Temel, J. A. Greer, A. Muzikansky et al., “Early palliative care for patients with metastatic non-small-cell lung cancer,” The New England Journal of Medicine, vol. 363, no. 8, pp. 733–742, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. T. Morita, T. Akechi, M. Ikenaga et al., “Late referrals to specialized palliative care service in Japan,” Journal of Clinical Oncology, vol. 23, no. 12, pp. 2637–2644, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. C. Zimmermann, R. Riechelmann, M. Krzyzanowska, G. Rodin, and I. Tannock, “Effectiveness of specialized palliative care: a systematic review,” Journal of the American Medical Association, vol. 299, no. 14, pp. 1698–1709, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. “Trabectedin for the treatment of advanced soft tissue sarcoma,” National Institute for Health and Clinical Excellence (NICE) February 2010, http://www.nice.org.uk/.
  20. C. S. Cleeland and C. C. Reyes-Gibby, “When is it justified to treat symptoms? Measuring symptom burden,” Oncology, vol. 16, no. 9, supplement 10, pp. 64–70, 2002. View at Google Scholar · View at Scopus
  21. World Health Organisation, Cancer Pain Relief with a Guide to Opioid Availability, WHO, Geneva, Switzerland, 2nd edition, 1996.
  22. M. H. J. van den Beuken-van Everdingen, J. M. de Rijke, A. G. Kessels, H. C. Schouten, M. van Kleef, and J. Patijn, “Prevalence of pain in patients with cancer: a systematic review of the past 40 years,” Annals of Oncology, vol. 18, no. 9, pp. 1437–1449, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. N. Penel, M. V. Glabbeke, S. Mathoulin-Pelissier et al., “Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma,” British Journal of Cancer, vol. 104, no. 10, pp. 1544–1550, 2011. View at Publisher · View at Google Scholar · View at PubMed
  24. “For better, for worse? A review of the care of patients who died within 30 days of receiving systemic anti-cancer therapy,” A report by the National Confidential Enquiry into Patient Outcome 2008, http://www.ncepod.org.uk/.
  25. Department of Health End of Life Care Strategy, “Promoting high quality care for all adults at the end of life,” Department of Health, London, UK, 2008, http://www.endoflifecareforadults.nhs.uk/.
  26. T. Iwashyna and N. Christakis, “Attitude and self-reported practice regarding hospice referral in a national sample if internists,” Journal of Palliative Medicine, vol. 1, pp. 241–248, 1998. View at Google Scholar
  27. M. J. Stillman and K. L. Syrjala, “Differences in physician access patterns to hospice care,” Journal of Pain and Symptom Management, vol. 17, no. 3, pp. 157–163, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Morita, S. Chihara, and T. Kashiwagi, “Family satisfaction with inpatient palliative care in Japan,” Palliative Medicine, vol. 16, no. 3, pp. 185–193, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Costantini, F. Toscani, M. Gallucci et al., “Terminal cancer patients and timing of referral to palliative care: a multicenter prospective cohort study,” Journal of Pain and Symptom Management, vol. 18, no. 4, pp. 243–252, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. E. B. Lamont and N. A. Christakis, “Physician factors in the timing of cancer patient referral to hospice palliative care,” Cancer, vol. 94, no. 10, pp. 2733–2737, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. P. D. Good, J. Cavenagh, and P. J. Ravenscroft, “Survival after enrollment in an Australian palliative care program,” Journal of Pain and Symptom Management, vol. 27, no. 4, pp. 310–315, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. N. A. Christakis and J. J. Escarce, “Survival of medicare patients after enrollment in hospice programs,” The New England Journal of Medicine, vol. 335, no. 3, pp. 172–178, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. N. Ahmed, J. C. Bestall, S. H. Ahmedzai, S. A. Payne, D. Clark, and B. Noble, “Systematic review of the problems and issues of accessing specialist palliative care by patients, carers and health and social care professionals,” Palliative Medicine, vol. 18, no. 6, pp. 525–542, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. K. S. Ogle, B. Mavis, and G. K. Wyatt, “Physicians and hospice care: attitudes, knowledge, and referrals,” Journal of Palliative Medicine, vol. 5, no. 1, pp. 85–92, 2002. View at Google Scholar · View at Scopus
  35. B. T. Friedman, M. Kay Harwood, and M. Shields, “Barriers and enablers to hospice referrals: an expert overview,” Journal of Palliative Medicine, vol. 5, no. 1, pp. 73–80, 2002. View at Google Scholar · View at Scopus
  36. D. J. Wood, D. Clark, and A. C. Gatrell, “Equity of access to adult hospice inpatient care within north-west England,” Palliative Medicine, vol. 18, no. 6, pp. 543–549, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Beccaro, M. Costantini, D. F. Merlo et al., “Inequity in the provision of and access to palliative care for cancer patients. Results from the Italian survey of the dying of cancer (ISDOC),” BMC Public Health, vol. 7, article 66, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. C. X. Pan, R. S. Morrison, D. E. Meier et al., “How prevalent are hospital-based palliative care programs? Status report and future directions,” Journal of Palliative Medicine, vol. 4, no. 3, pp. 315–324, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Goldsmith, J. Dietrich, Q. Du, and R. S. Morrison, “Variability in access to hospital palliative care in the United States,” Journal of Palliative Medicine, vol. 11, no. 8, pp. 1094–1102, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. J. Cohen, D. Wilson, A. Thurston et al., “Access to palliative care services in hospital: a matter of being in the right hospital. Hospital charts study in a Canadian city,” Palliative Medicine. In press. View at Publisher · View at Google Scholar · View at PubMed
  41. T. Lynch, D. Clark, C. Centeno et al., “Barriers to the development of palliative care in the countries of Central and Eastern Europe and the Commonwealth of Independent States,” Journal of Pain and Symptom Management, vol. 37, no. 3, pp. 305–315, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. B. Gray, England's Approach to Improving End-of-Life Care: A Strategy for Honoring Patients' Choices, The Commonwealth Fund, July 2011.
  43. J. Greenhalgh and K. Meadows, “The effectiveness of the use of patient-based measures of health in routine practice in improving the process and outcomes of patient care: a literature review,” Journal of Evaluation in Clinical Practice, vol. 5, no. 4, pp. 401–416, 1999. View at Publisher · View at Google Scholar · View at Scopus